Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 5RO1NS115662
NIH
Grant: 5RO1AR073379
NINDS NIH HHS
Grant: R01 NS115662
NIAMS NIH HHS
Grant: R01 AR073379
National Institutes of Health
Grant: 5R01AR073379-03
GSK3 beta study in patients with Myotonic Dystrophy 1
National Institutes of Health
Grant: 5R01NS115662-03
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities
FWCI
0.46
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals